These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 29268799

  • 1. Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.
    Tawaratsumida H, Setoguchi T, Arishima Y, Ohtsubo H, Akimoto M, Ishidou Y, Nagano S, Taketomi E, Sunahara N, Komiya S.
    BMC Res Notes; 2017 Dec 21; 10(1):765. PubMed ID: 29268799
    [Abstract] [Full Text] [Related]

  • 2. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
    Tokumoto H, Tominaga H, Arishima Y, Jokoji G, Akimoto M, Ohtsubo H, Taketomi E, Sunahara N, Nagano S, Ishidou Y, Komiya S, Setoguchi T.
    Nutrients; 2018 Feb 18; 10(2):. PubMed ID: 29463015
    [Abstract] [Full Text] [Related]

  • 3. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T.
    Rheumatol Int; 2018 May 18; 38(5):777-784. PubMed ID: 29294175
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for vertebral fracture in rheumatoid arthritis patients using biological disease-modifying anti-rheumatic drugs (cases over 5 years): An observational study.
    Tokumoto H, Tominaga H, Maeda S, Sasaki H, Kawamura I, Setoguchi T, Taniguchi N.
    Medicine (Baltimore); 2024 Jul 05; 103(27):e38740. PubMed ID: 38968492
    [Abstract] [Full Text] [Related]

  • 5. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.
    J Rheumatol; 1997 Aug 05; 24(8):1489-94. PubMed ID: 9263140
    [Abstract] [Full Text] [Related]

  • 6. Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study.
    Chen MH, Yu SF, Chen JF, Chen WS, Liou TL, Chou CT, Hsu CY, Lai HM, Chen YC, Tsai CY, Cheng TT.
    Front Immunol; 2021 Aug 05; 12():783030. PubMed ID: 34987510
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B, Flipo RM, Blanckaert F, Duquesnoy B, Marchandise X, Delcambre B.
    Rev Rhum Engl Ed; 1997 Aug 05; 64(7-9):451-8. PubMed ID: 9338926
    [Abstract] [Full Text] [Related]

  • 8. Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide.
    Kwon OC, Oh JS, Hong S, Lee CK, Yoo B, Kim YG.
    Clin Exp Rheumatol; 2019 Aug 05; 37(5):813-819. PubMed ID: 30767868
    [Abstract] [Full Text] [Related]

  • 9. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S.
    J Rheumatol; 2000 Nov 05; 27(11):2582-9. PubMed ID: 11093437
    [Abstract] [Full Text] [Related]

  • 10. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study.
    Lee JS, Lim DH, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.
    Rheumatol Int; 2020 Mar 05; 40(3):481-487. PubMed ID: 31414225
    [Abstract] [Full Text] [Related]

  • 11. The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis.
    Rexhepi S, Rexhepi M, Sahatçiu-Meka V, Mahmutaj V, Boshnjaku S.
    Med Arch; 2016 Apr 05; 70(2):101-3. PubMed ID: 27147781
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
    Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.
    Ann Rheum Dis; 2009 Mar 05; 68(3):373-6. PubMed ID: 18408246
    [Abstract] [Full Text] [Related]

  • 13. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
    Juhász B, Gulyás K, Horváth Á, Pethő Z, Bhattoa HP, Váncsa A, Szekanecz É, Horváth C, Kocsis J, Horváth Z, Hodosi K, Szántó S, Szűcs G, Szekanecz Z.
    Osteoporos Int; 2017 Apr 05; 28(4):1271-1277. PubMed ID: 27942777
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
    Mazzantini M, Di Munno O, Sinigaglia L, Bianchi G, Rossini M, Mela Q, Del Puente A, Frediani B, Cantatore F, Adami S.
    Clin Exp Rheumatol; 2007 Apr 05; 25(5):709-15. PubMed ID: 18078618
    [Abstract] [Full Text] [Related]

  • 15. Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis.
    Theander L, Willim M, Nilsson JÅ, Karlsson M, Åkesson KE, Jacobsson LTH, Turesson C.
    RMD Open; 2020 Feb 05; 6(1):. PubMed ID: 32519976
    [Abstract] [Full Text] [Related]

  • 16. Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis.
    Lee SG, Park YE, Park SH, Kim TK, Choi HJ, Lee SJ, Kim SI, Lee SH, Kim GT, Lee JW, Lee JH, Baek SH.
    Int J Rheum Dis; 2012 Jun 05; 15(3):289-96. PubMed ID: 22709491
    [Abstract] [Full Text] [Related]

  • 17. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.
    Osteoporos Int; 2013 Apr 05; 24(4):1429-36. PubMed ID: 23011680
    [Abstract] [Full Text] [Related]

  • 18. Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics.
    Takahashi K, Setoguchi T, Tawaratsumida H, Arishima Y, Tominaga H, Ishidou Y, Nagano S, Shigemizu S, Aoki N, Akimoto M, Otsubo H, Matsuda T, Kakoi H, Izumi T, Nakamura S, Yokouchi M, Sunahara N, Komiya S.
    BMC Musculoskelet Disord; 2015 Sep 30; 16():269. PubMed ID: 26420629
    [Abstract] [Full Text] [Related]

  • 19. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Anno S, Koike T.
    Rheumatol Int; 2017 Jun 30; 37(6):999-1005. PubMed ID: 28405825
    [Abstract] [Full Text] [Related]

  • 20. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C, Karlsson M, Akesson K, Jacobsson L.
    Scand J Rheumatol; 2008 Jun 30; 37(4):248-54. PubMed ID: 18612924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.